Diagnosing and Managing Non-Inflammatory Arthritis Flares

Diagnostic Approach

• Inflammatory markers (ESR/CRP) should be normal or only mildly elevated in non-inflammatory arthritis, significantly elevated markers suggest inflammatory arthritis instead, according to the Annals of the Rheumatic Diseases 1
• Autoantibodies (RF, ACPA, ANA) should be negative in non-inflammatory arthritis, positive results indicate inflammatory or autoimmune arthritis, as stated by the Annals of the Rheumatic Diseases and other sources 2

Management of Acute Flares

• The American College of Rheumatology recommends adding NSAIDs if acetaminophen is inadequate for pain control, after evaluating gastrointestinal, renal, and cardiovascular risk 6
• The European League Against Rheumatism suggests that systemic corticosteroids are generally not recommended for OA flares, unlike inflammatory arthritis, and intra-articular corticosteroid injections can provide short-term relief for knee osteoarthritis 6

Critical Pitfalls to Avoid

• The American College of Rheumatology warns that misdiagnosing inflammatory arthritis as OA can lead to delayed treatment, and if morning stiffness exceeds 30 minutes, multiple joints are involved, or inflammatory markers are elevated, suspect inflammatory arthritis instead 1, 6
• The American College of Radiology advises that delaying joint aspiration when infection is suspected can lead to serious consequences, and aspiration should be performed promptly to analyze for cell count, Gram stain, culture, and crystals 4, 5